Header Logo

Connection

TARIQ SHAFI to Renal Dialysis

Back to Details
This is a "connection" page, showing publications TARIQ SHAFI has written about Renal Dialysis.
TARIQ SHAFI
Connection Strength
9.932
Renal Dialysis
  1. Adequacy Measurement for the 21st Century: Revisiting Kt/Vurea. Adv Kidney Dis Health. 2025 09; 32(5):411-421.
    View in: PubMed
    Score: 0.543
  2. Patients' and family members' perspectives on arrhythmias and sudden death in dialysis: the HeartLink focus groups pilot study. BMC Nephrol. 2021 05 27; 22(1):199.
    View in: PubMed
    Score: 0.404
  3. Contribution of 'clinically negligible' residual kidney function to clearance of uremic solutes. Nephrol Dial Transplant. 2020 05 01; 35(5):846-853.
    View in: PubMed
    Score: 0.375
  4. Prevalence and Persistence of Uremic Symptoms in Incident Dialysis Patients. Kidney360. 2020 Feb; 1(2):86-92.
    View in: PubMed
    Score: 0.369
  5. Serum Metabolites and Cardiac Death in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2019 05 07; 14(5):747-749.
    View in: PubMed
    Score: 0.348
  6. Point-of-care ultrasound education to improve care of dialysis patients. Semin Dial. 2018 03; 31(2):154-162.
    View in: PubMed
    Score: 0.319
  7. Measurement and Estimation of Residual Kidney Function in Patients on Dialysis. Adv Chronic Kidney Dis. 2018 01; 25(1):93-104.
    View in: PubMed
    Score: 0.319
  8. Results of the HEMO Study suggest that p-cresol sulfate and indoxyl sulfate are not associated?with?cardiovascular outcomes. Kidney Int. 2017 12; 92(6):1484-1492.
    View in: PubMed
    Score: 0.309
  9. Autonomic dysfunction as a mechanism of intradialytic blood pressure instability. Semin Dial. 2017 11; 30(6):537-544.
    View in: PubMed
    Score: 0.309
  10. Residual Kidney Function: Implications in the Era of Personalized Medicine. Semin Dial. 2017 05; 30(3):241-245.
    View in: PubMed
    Score: 0.301
  11. Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices. Medicine (Baltimore). 2017 Feb; 96(5):e5924.
    View in: PubMed
    Score: 0.300
  12. Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2017 Jul; 70(1):48-58.
    View in: PubMed
    Score: 0.298
  13. Hemodialysis Prescription for Incident Patients: Twice Seems Nice, But Is It Incremental? Am J Kidney Dis. 2016 08; 68(2):180-183.
    View in: PubMed
    Score: 0.289
  14. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J Am Soc Nephrol. 2017 Jan; 28(1):321-331.
    View in: PubMed
    Score: 0.289
  15. In Reply to 'Plasma Clearance of Iohexol in Hemodialysis Patients Requires Prolonged Blood Sampling'. Am J Kidney Dis. 2016 May; 67(5):811-2.
    View in: PubMed
    Score: 0.284
  16. Estimating residual kidney function in dialysis patients without urine collection. Kidney Int. 2016 May; 89(5):1099-1110.
    View in: PubMed
    Score: 0.279
  17. Plasma Iohexol Clearance for Assessing Residual Kidney Function in Dialysis Patients. Am J Kidney Dis. 2015 Oct; 66(4):728-30.
    View in: PubMed
    Score: 0.269
  18. Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators. PLoS One. 2015; 10(5):e0126048.
    View in: PubMed
    Score: 0.265
  19. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2014 Sep; 64(3):443-51.
    View in: PubMed
    Score: 0.247
  20. Hypertension in hemodialysis patients: an opinion-based update. Semin Dial. 2014 Mar; 27(2):146-53.
    View in: PubMed
    Score: 0.243
  21. Predialysis systolic BP variability and outcomes in hemodialysis patients. J Am Soc Nephrol. 2014 Apr; 25(4):799-809.
    View in: PubMed
    Score: 0.242
  22. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care. 2013 Jun; 36(6):1522-33.
    View in: PubMed
    Score: 0.225
  23. Serum ?-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2012 Sep; 7(9):1435-45.
    View in: PubMed
    Score: 0.218
  24. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2010 Aug; 56(2):348-58.
    View in: PubMed
    Score: 0.189
  25. Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies. Nat Commun. 2025 11 27; 16(1):11689.
    View in: PubMed
    Score: 0.138
  26. Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease? Curr Hypertens Rep. 2024 Dec; 26(12):463-474.
    View in: PubMed
    Score: 0.125
  27. Plasma metabolites and physical function in patients undergoing hemodialysis. Sci Rep. 2024 04 10; 14(1):8427.
    View in: PubMed
    Score: 0.123
  28. Designing an Implementable Clinical Prediction Model for Near-Term Mortality and Long-Term Survival in Patients on Maintenance Hemodialysis. Am J Kidney Dis. 2024 07; 84(1):73-82.
    View in: PubMed
    Score: 0.122
  29. Evaluation of a large-scale aptamer proteomics platform among patients with kidney failure on dialysis. PLoS One. 2023; 18(12):e0293945.
    View in: PubMed
    Score: 0.120
  30. Drug Selection for Treating Hypertension in Dialysis Patients: More to Consider than BP-Lowering Potency. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1084-1086.
    View in: PubMed
    Score: 0.095
  31. Lower levels of proteinuria are associated with elevated mortality in incident dialysis patients. PLoS One. 2019; 14(12):e0226866.
    View in: PubMed
    Score: 0.091
  32. Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 03; 75(3):394-403.
    View in: PubMed
    Score: 0.091
  33. Vascular Calcification Markers and Hemodialysis Vascular Access Complications. Am J Nephrol. 2018; 48(5):330-338.
    View in: PubMed
    Score: 0.085
  34. Intradialytic Activities and Health-Related Quality of Life Among Hemodialysis Patients. Am J Nephrol. 2018; 48(3):181-189.
    View in: PubMed
    Score: 0.084
  35. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018 07 01; 33(7):1215-1223.
    View in: PubMed
    Score: 0.083
  36. Frequency of arrhythmia symptoms and acceptability of implantable cardiac monitors in Hemodialysis patients. BMC Nephrol. 2017 Oct 10; 18(1):309.
    View in: PubMed
    Score: 0.079
  37. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease. Semin Dial. 2017 05; 30(3):251-261.
    View in: PubMed
    Score: 0.076
  38. The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol. 2017 May 08; 12(5):839-847.
    View in: PubMed
    Score: 0.076
  39. Intravenous iron administration strategies and anemia management in hemodialysis patients. Nephrol Dial Transplant. 2017 01 01; 32(1):173-181.
    View in: PubMed
    Score: 0.074
  40. Hand-carried ultrasound use in clinical nephrology: Case report. Medicine (Baltimore). 2016 Jul; 95(30):e4166.
    View in: PubMed
    Score: 0.072
  41. Effect of a sustained difference in hemodialytic clearance on the plasma levels of p-cresol sulfate and indoxyl sulfate. Nephrol Dial Transplant. 2016 08; 31(8):1335-41.
    View in: PubMed
    Score: 0.071
  42. Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study. J Am Soc Nephrol. 2016 Nov; 27(11):3469-3478.
    View in: PubMed
    Score: 0.071
  43. Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. BMC Nephrol. 2016 Feb 20; 17:18.
    View in: PubMed
    Score: 0.070
  44. A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysis. BMC Nephrol. 2015 Aug 14; 16:138.
    View in: PubMed
    Score: 0.068
  45. Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study. Nephrol Dial Transplant. 2015 Apr; 30(4):667-75.
    View in: PubMed
    Score: 0.064
  46. Intravenous iron exposure and mortality in patients on hemodialysis. Clin J Am Soc Nephrol. 2014 Nov 07; 9(11):1930-9.
    View in: PubMed
    Score: 0.064
  47. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014 Dec; 64(6):954-61.
    View in: PubMed
    Score: 0.064
  48. An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States. Kidney Int. 2014 Oct; 86(4):798-809.
    View in: PubMed
    Score: 0.062
  49. Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD. Am J Kidney Dis. 2014 May; 63(5):806-15.
    View in: PubMed
    Score: 0.061
  50. Trends in anemia management in US hemodialysis patients 2004-2010. BMC Nephrol. 2013 Dec 01; 14:264.
    View in: PubMed
    Score: 0.060
  51. Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months. BMC Nephrol. 2013 Nov 12; 14:249.
    View in: PubMed
    Score: 0.060
  52. Predialysis health, dialysis timing, and outcomes among older United States adults. J Am Soc Nephrol. 2014 Feb; 25(2):370-9.
    View in: PubMed
    Score: 0.060
  53. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators. BMC Nephrol. 2013 Jun 27; 14:134.
    View in: PubMed
    Score: 0.058
  54. Association of intradialytic blood pressure variability with increased all-cause and cardiovascular mortality in patients treated with long-term hemodialysis. Am J Kidney Dis. 2013 Jun; 61(6):966-74.
    View in: PubMed
    Score: 0.057
  55. Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study. BMC Nephrol. 2012 Dec 06; 13:167.
    View in: PubMed
    Score: 0.056
  56. Machine learning-based prediction models in medical decision-making in kidney disease: patient, caregiver, and clinician perspectives on trust and appropriate use. J Am Med Inform Assoc. 2025 01 01; 32(1):51-62.
    View in: PubMed
    Score: 0.032
  57. Comparative Effectiveness of Alternative Treatment Approaches to Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis: An Observational Trial Emulation. Am J Kidney Dis. 2024 01; 83(1):58-70.
    View in: PubMed
    Score: 0.030
  58. Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease. Curr Hypertens Rep. 2022 10; 24(10):413-424.
    View in: PubMed
    Score: 0.027
  59. Frailty, Age, and Postdialysis Recovery Time in a Population New to Hemodialysis. Kidney360. 2021 09 30; 2(9):1455-1462.
    View in: PubMed
    Score: 0.025
  60. Indoxyl sulfate is associated with mortality after AKI - more evidence needed! BMC Nephrol. 2019 07 26; 20(1):280.
    View in: PubMed
    Score: 0.022
  61. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol. 2015; 42(1):25-34.
    View in: PubMed
    Score: 0.017
  62. Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Aug 07; 16:131.
    View in: PubMed
    Score: 0.017
  63. Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Apr 24; 16:63.
    View in: PubMed
    Score: 0.017
  64. Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study. BMC Nephrol. 2014 May 01; 15:68.
    View in: PubMed
    Score: 0.015
  65. Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014 Apr; 9(4):745-55.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.